z-logo
open-access-imgOpen Access
CD8 + T cells specific for conserved coronavirus epitopes correlate with milder disease in patients with COVID-19
Author(s) -
Vamsee Mallajosyula,
Conner Ganjavi,
Saborni Chakraborty,
Alana M. McSween,
Ana Jimena Pavlovitch-Bedzyk,
Julie Wilhelmy,
Allison Nau,
Monali Manohar,
Kari C. Nadeau,
Mark M. Davis
Publication year - 2021
Publication title -
science immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 8.83
H-Index - 51
ISSN - 2470-9468
DOI - 10.1126/sciimmunol.abg5669
Subject(s) - coronavirus , epitope , virology , covid-19 , antigen , biology , cd8 , disease , conserved sequence , immunology , base sequence , medicine , gene , genetics , infectious disease (medical specialty) , pathology , outbreak
A central feature of the SARS-CoV-2 pandemic is that some individuals become severely ill or die, whereas others have only a mild disease course or are asymptomatic. Here we report development of an improved multimeric αβ T cell staining reagent platform, with each maxi-ferritin "spheromer" displaying 12 peptide-MHC complexes. Spheromers stain specific T cells more efficiently than peptide-MHC tetramers and capture a broader portion of the sequence repertoire for a given peptide-MHC. Analyzing the response in unexposed individuals, we find that T cells recognizing peptides conserved amongst coronaviruses are more abundant and tend to have a "memory" phenotype, compared to those unique to SARS-CoV-2. Significantly, CD8 + T cells with these conserved specificities are much more abundant in COVID-19 patients with mild disease versus those with a more severe illness, suggesting a protective role.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom